In this issue, Li et al show that EIF1AX inhibits the transcription of critical cell‐cycle regulator p21 in a p53‐independent way and then promotes breast cancer cell proliferation and tumorigenesis through promoting the G1/S transition in cell cycle. The gene discussed is TP53; the disease is breast carcinoma.